Emergent BioSolutions Inc.
US ˙ NYSE ˙ US29089Q1058

SecurityEBS / Emergent BioSolutions Inc.
InstitutionCapstone Asset Management Co
Latest Disclosed Ownership6,910 shares
Latest Disclosed Value $ 234,000
Capstone Asset Management Co reports 9.91% decrease in ownership of EBS / Emergent BioSolutions Inc.

On July 10, 2017 - Capstone Asset Management Co filed a 13F-HR form disclosing ownership of 6,910 shares of Emergent BioSolutions Inc. (US:EBS) valued at $234,318 USD as of June 30, 2017. The entity filed a previous 13F-HR on April 12, 2017 disclosing 7,670 shares of Emergent BioSolutions Inc.. This represents a change in shares of -9.91% during the quarter. The current value of the position is $54,796 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2017-07-10 2017-06-30 13F EMERGENT BIOSOLUTIONS INC COM COM 29089Q105 6,910 -760 -9.91 234 4.93 0.0065
2017-04-12 2017-03-31 13F EMERGENT BIOSOLUTIONS INC COM COM 29089Q105 7,670 -1,060 -12.14 223 -22.30 0.0062
2017-01-17 2016-12-31 13F EMERGENT BIOSOLUTIONS INC COM COM 29089Q105 8,730 -7,280 -45.47 287 -43.17 0.0082
2016-10-12 2016-09-30 13F EMERGENT BIOSOLUTIONS INC COM COM 29089Q105 16,010 30 0.19 505 12.47 0.0145
2016-07-13 2016-06-30 13F EMERGENT BIOSOLUTIONS INC COM COM 29089Q105 15,980 2,420 17.85 449 -8.92 0.0135
2016-04-11 2016-03-31 13F EMERGENT BIOSOLUTIONS INC COM COM 29089Q105 13,560 -100 -0.73 493 -9.87 0.0142
2016-01-14 2015-12-31 13F EMERGENT BIOSOLUTIONS INC COM COM 29089Q105 13,660 3,960 40.82 547 98.19 0.0157
2015-10-20 2015-09-30 13F EMERGENT BIOSOLUTIONS INC COM COM 29089Q105 9,700 870 9.85 276 -5.15 0.0085
2015-07-15 2015-06-30 13F EMERGENT BIOSOLUTIONS INC COM COM 29089Q105 8,830 -4,730 -34.88 291 -25.38 0.0084
2015-04-10 2015-03-31 13F EMERGENT BIOSOLUTIONS INC COM COM 29089Q105 13,560 1,190 9.62 390 15.73 0.0110
2015-01-20 2014-12-31 13F EMERGENT BIOSOLUTIONS INC COM COM 29089Q105 12,370 -1,590 -11.39 337 13.47 0.0098
2014-10-14 2014-09-30 13F EMERGENT BIOSOLUTIONS INC COM COM 29089Q105 13,960 0 0.00 297 -5.41 0.0101
2014-07-11 2014-06-30 13F EMERGENT BIOSOLUTIONS INC COM COM 29089Q105 13,960 2,356 20.30 314 7.17 0.0100
2014-04-22 2014-03-31 13F EMERGENT BIOSOLUTIONS INC COM COM 29089Q105 11,604 -250 -2.11 293 7.33 0.0090
2014-02-04 2013-12-31 13F EMERGENT BIOSOLUTIONS INC COM COM 29089Q105 11,854 -120 -1.00 273 19.74 0.0079
2013-10-31 2013-09-30 13F EMERGENT BIOSOLUTIONS INC COM COM 29089Q105 11,974 400 3.46 228 36.53 0.0055
2013-08-05 2013-06-30 13F EMERGENT BIOSOLUTIONS INC COM COM 29089Q105 11,574 11,574 167 0.0044
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.